Eli Lilly’s stock checks all the boxes for a split. the price keeps climbing, the company is on fire, and it’s a bull market.

Eli Lilly stock has regained all-time highs, outpacing rivals in the obesity drug market. Click here to read my latest ...

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

The maker of the weight-loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of these blockbuster ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of ABL Bio, after it struck a $2.6 billion licensing and joint ...

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...

Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain ...

Here are some of the stocks on the move Monday, Nov. 17. Novo Nordisk (NVO) announced it will cut the prices for consumers ...

US accounts for 72.7% of the MSCI World Index, compared with just 2.6% for Europe’s biggest stock market, France ...

The drugmaker said Monday that it has started selling higher doses of the injectable obesity treatment for $349 a month to ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...